ImmunologybioRxivPreprint
An autologous cell-based therapeutic vaccine expressing IL6/1 fusokine drives robust anti-tumor response against ovarian cancer.
Sejal Sharma, Rahul Das, Andrea Pennati…·Jacques Galipeau
This paper develops an IL6/1 fusokine that enhances T cell survival and anti-tumor response in a preclinical ovarian cancer model.
DOI 10.64898/2026.05.05.721149